Adenomatous polyposis coli (APC/Apc) gene encodes a key tumor suppressor whose mutations activate b-catenin/ T-cell factor (TCF)-mediated transcription (canonical Wnt signaling). Here, we show that Wnt signaling can cause chromosomal instability (CIN). As an indicator of CIN, we scored anaphase bridge index (ABI) in mouse polyps and ES cells where Wnt signaling was activated by Apc or b-catenin mutations. We found three to nine times higher ABI than in wild-type controls. Furthermore, karyotype analysis confirmed that the Wnt signalactivated ES cells produced new chromosomal aberrations at higher rates; hence CIN. Consistently, expression of dominant-negative TCFs in these cells reduced their ABI. We also found that Wnt signal activation increased phosphorylation of Cdc2 (Cdk1) that inhibited its activity, and suppressed apoptosis upon exposure of the cells to nocodazole or colcemid. The data suggest that Wnt signaling stimulates the cells to escape from mitotic arrest and apoptosis, resulting in CIN. In human gastric cancer tissues with nuclear b-catenin, ABI was significantly higher than in those without. These results collectively indicate that b-catenin/TCF-mediated transcription itself increases CIN through dysregulation of G2/M progression.
Introduction
Genetic instabilities are generally divided into microsatellite instability (MIN) that associates with higher mutation rate, and chromosomal instability (CIN) that can induce gross chromosomal rearrangements, including chromosome number changes . MIN can be caused by the mutations in mismatch repair genes but is unusual in sporadic colon cancer, whereas CIN is frequently found in the cancer and believed to facilitate the tumorigenesis . In yeast Saccharomyces, tens of mutants were isolated that show CIN (Kolodner et al., 2002) . These genes are involved in S-phase checkpoints, recombination pathways and telomere maintenance. Consistently, human homologs of several of these genes have well-established roles as tumor suppressors, such as ATR/ATM, MRE11, NBS1, BLM/WRN/RTS (Kolodner et al., 2002) . However, mutations in these genes account for only a tiny fraction of human cancers with CIN. Although mutations in BuB1, a mitotic checkpoint kinase, have been reported in a relatively small fraction of colon cancer (Cahill et al., 1998) , expression of related kinase BubR1 is reduced in 30% of colon cancer (Shin et al., 2003) . Recently, mutations were reported in the hCDC4 gene in B12% of colon cancer lesions . These results suggest that there are some more mechanisms and gene mutations that can contribute to the CIN phenotype in colon cancer.
Activation of the canonical Wnt signal pathway induces transcription of a new set of genes through the b-catenin/T-cell factor (TCF) complex, which regulates cell proliferation and differentiation (Kielman et al., 2002; Giles et al., 2003) . In most colon cancer cells, the pathway is activated through mutations in the adenomatous polyposis coli (APC), AXIN1 or b-catenin (CTNNB1) gene. Recent reports have suggested that APC protein plays additional roles in chromosome segregation and CIN (Fodde et al., 2001; Kaplan et al., 2001; Dikovskaya et al., 2004; Green and Kaplan, 2004; Tighe et al., 2004) . It has been found that truncation mutations in the APC gene cause structural abnormalities of chromosomes (Fodde et al., 2001) , aneuploidy (Fodde et al., 2001; Kaplan et al., 2001) and spindle aberrations (Fodde et al., 2001) . It has been also reported that APC localizes to the kinetochore (Fodde et al., 2001; Kaplan et al., 2001) . These reports suggest that lack of APC is involved in cancer progression through induction of CIN. In addition, recent analyses have indicated that N-terminal APC fragments can suppress the mitotic spindle checkpoint and induce CIN (Tighe et al., 2004) .
Although Wnt signal-mediated transcription is activated in cells lacking the wild-type APC, the roles of the signaling in CIN have not been understood. Here, we have investigated whether activation of the canonical Wnt signaling pathway by itself plays any roles in CIN.
Results
High anaphase bridge index in polyp adenomas with Wnt signal activation An anaphase bridge is found as an extended chromosome bridging between the two spindle poles in cells at anaphase, during which the sister chromatids segregate to the opposite spindle poles (Gisselsson et al., 2000; . As anaphase bridge index (ABI) has been reported to correlate with the extent of CIN (Gisselsson et al., 2000) , it has been used as a marker of CIN (Gisselsson et al., 2000; Rudolph et al., 2001) .
To investigate the possible roles of Wnt signaling in CIN, we first scored ABI in two types of mouse intestinal polyps with activated Wnt signaling. One type is initiated by conditional expression of a stable b-catenin allele generated by Cre recombinase driven by either promoter of the liver fatty acid-binding protein (Fabpl) or cytokeratin 19 (K19; Krt1-19) gene (Harada et al., 1999) . The other type is initiated by lack of both wild-type Apc alleles through loss of heterozygosity (LOH) in the Apc D716 (Apc
) mutant mouse (Oshima et al., 1995) . In the b-catenin mutant mice expressing Cre in the small intestine, b-catenin protein is stabilized by Cre-mediated deletion of the exon 3 that encodes amino acids, including all four phosphorylation targets for ubiquitylation (Giles et al., 2003) . On the other hand, b-catenin protein in the Apc D716 mutant mouse is stabilized because glycogen synthase kinase 3b-mediated phosphorylation of b-catenin is suppressed due to the absence of intact APC protein that provides the scaffold for these proteins (Giles et al., 2003) . As anticipated, b-catenin was localized in the adenoma epithelial nuclei, whereas it was found mostly in the cytoplasmic membrane in the normal (non-polyp) epithelium in the b-catenin mutant mouse ( Figure 1a ; Harada et al., 1999) as well as in the Apc D716 mouse (Harada et al., 1999) . In the normal intestinal epithelium, we found anaphase bridges only rarely, with B1% ABI in both Apc D716 and floxed b-catenin (Catnb
) mice as well as in the wild type (Figure 1b and c, and data not shown). In the Apc D716 polyps, ABI was B3 times higher than in the normal epithelium (2.770.7%, mean7s.d.; Figure 1b and c). We found five to nine times higher ABI in the polyps developed in the b-catenin mutants crossed with either Fabpl-Cre or K19-Cre mouse strain (Figure 1b and c Changes in ABI associated with Wnt signal suppression or forced activation in ES and colon cancer cells To investigate the role of b-catenin/TCF transcription in CIN further, we suppressed Wnt signal transcription in the ES cells using two types of dominant-negative TCFs.
Carboxyl-terminally truncated TCF4DC lacks the DNA-binding domain, whereas amino-terminally truncated dn-TCF4 and dn-TCF1 are devoid of the b-catenin-binding domain (van de Wetering et al., 2002; Sekiya et al., 2004) . The cDNA constructs were placed in a retrovirus expression vector and transduced into the ES cells as described in Materials and methods. We first verified reduction in the Wnt signal transcription in ES cell clones stably expressing these constructs using reporter gene assays, that is, we determined the transcriptional activity of a model Wnt target sequence (Topflash) relative to its mutant form (Fopflash; Korinek et al., 1997) . In wild-type ES cells, none of these constructs affected the transcriptional ratio between Topflash and Fopflash (Figure 2a ), indicating that no activation of the Wnt signaling had occurred. In Chromosomal instability by Wnt signaling K Aoki et al both Apc
-/-and b-catenin Dex3 ES cell lines, all these dominant-negative TCF constructs reduced the transcriptional ratio from five to six times to one to two of the control LacZ-expressing ES cell line, with simultaneous reductions in ABI from B30 to 5-15% (Figure 2a and b; Po0.01). In wild-type ES cells, ABI was unaffected by any of the dominant-negative constructs (Figure 2b ). These data taken together suggest that Wnt transcription can induce CIN also in ES cells.
We further investigated the roles of Wnt signaling in CIN of human colon cancer cells. The interaction between APC and b-catenin suggested that expression of the stable b-catenin in ES cells might cause CIN indirectly through interfering with the kinetochore binding of APC (Fodde et al., 2001; Kaplan et al., 2001) . To exclude such a possibility, we chose cells that lack both wild-type APC alleles but show little CIN, that is, DLD-1 cells that are MIN cell line with near-diploid chromosome content, and show minimal CIN (Aoki et al., 2003; Stewenius et al., 2005) . Notably, DLD-1 cells lack full-length APC, but express its C-terminally truncated protein that cannot bind to the kinetochore (Homfray et al., 1998; Fodde et al., 2001) . In this cell line, the Wnt transcription is relatively lower than those in other cells with Wnt signal activation (van de Wetering et al., 2002) . Thus, we induced a dominant-active TCF4 (TCF4-VP16 where human TCF4 was fused with the transactivation domain of Herpes simplex virus-VP16; Triezenberg et al., 1988) in these cells, using a doxycyclin-inducible TetOff system (Materials and methods). Transcriptional activation was confirmed using Topflash and Fopflash reporters. Upon induction of TCF4-VP16, the transcriptional ratio increased three to five times in the DLD-1 cells (Figure 2c , clones 1 and 5). A control empty vector (DLD-1 control) did not affect the ratio (Figure 2c ). As expected, we found 2.3 times (clone 1) and 1.8 times (clone 5) higher ABI in the TCF4-VP16-induced DLD-1 clones than in uninduced cells (Figure 2d ), whereas a control empty vector (DLD-1 control) did not affect the ABI (Figure 2d ). These results indicate that forced activation of b-catenin/TCF transcription is sufficient to increase anaphase bridges, also in the human colon cancer cells.
Enhanced cell survival and escape from G2/M arrest upon prolonged microtubule disruption in cells with Wnt signal activation It has been reported that CIN can be caused by dysregulation of the mitotic spindle checkpoint that ensures accurate chromosome segregation during M phase (Michel et al., 2001; Shin et al., 2003) . In addition to G1 progression (van de Wetering et al., 2002) , Wnt signaling has been reported to be involved also in G2/M progression (Sekiya et al., 2002 (Figure 3a and b, and Supplementary Figure 2) . After 48-96 h with either agent, however, the surviving cell fraction that contained more than 8N DNA was significantly higher in both b-catenin Dex3 and Apc -/-ES cells. In contrast, the fraction that contained 4N DNA was significantly lower in both b-catenin Dex3 and Apc -/-ES cells. This is likely because Wnt signaling activation helps ES cells progress to the next cell cycle from G2/M block caused by nocodazole. These results suggest that Wnt-activated cells are more prone to become polyploid when treated with such agents.
In addition, we found less apoptotic cells (Sub-G1;o2N) in the mutant ES cell lines than in the wild type (Figure 3c) As these phenotypes were similar to those found for mutations in the mitotic checkpoint proteins Mad2 and BubR1 (Michel et al., 2001) , it was conceivable that Wnt signal activation affected the checkpoint and/or subsequent apoptotic pathway. We focused our attention to Cdc2 (Cdk1), because it is one of the key mitotic progression regulators under the checkpoint, and reduction of its activity is required for exit from the mitotic phase (Tan et al., 2002) . Upon activation of the spindle checkpoint by nocodazole, we found that the level of inhibitory phosphorylation at Tyr(Y)15 of Cdc2 was decreased in the cells, suggesting an increased activity of Cdc2 (Figure 3d and e). Compared with its phosphorylation levels in the wild-type, they were significantly higher in the Wnt signal-activated cells 12-24 h after nocodazole treatment (Figure 3d and e), suggesting that Cdc2 activation was suppressed partially by Wnt signaling. We also determined the kinase activity of Cdc2 on histone H1 substrate, and confirmed its reduction in Wnt-activated cells (Figure 3f ). In contrast, expression levels remained unchanged for Cdc2, cyclin B and Wnt-target gene products cyclin D1 (Tetsu and McCormick, 1999) and E1 (Botrugno et al., 2004) , c-myc (He et al., 1998) , and p21 (van de Wetering et al., 2002) (Figure 3e, Supplementary Figure 3 , and data not shown). We obtained essentially the same results with colcemid-treated cells as well (Supplementary Figure 3) . As suppression of Cdc2 activity is a prerequisite for progression of mitosis, these results suggest that Wnt signal-activated cells tend to escape the G2/M arrest and complete mitosis by reducing the Cdc2 activity, even when the cells activate the checkpoint. As apoptosis is also suppressed by Wnt signaling (Figure 3c) , it is conceivable that these cells enter the next cycle even if they are polyploid (>4N) or aneuploid. This interpretation is consistent with the reports that inhibition of Cdc2 through its phosphorylation at Y15 suppresses paclitaxelinduced apoptosis (Konishi et al., 2002; Tan et al., 2002) . These results may explain the increased ABI by Wnt signaling activation (Figure 1 ).
High ABI in 'intestinal-type' human gastric cancer tissues with Wnt signal activation As most colorectal cancer tissues show activation of b-catenin/TCF transcription (Giles et al., 2003) , we then examined human gastric cancer samples, with and without nuclear b-catenin staining, respectively, and determined their ABI. Histologically, they were classified as 'intestinal type' associated with intestinal metaplasia (Figure 4a-d) , or 'diffuse type' with undifferentiated morphology (Ushijima and Sasako, 2004) . In the intestinal-type gastric cancer, samples with nuclear b-catenin localization had higher ABI, with a stronger statistical significance (Figure 4e ; P ¼ 0.014), whereas in the diffuse type, there was less correlation (Figure 4f ; P ¼ 0.14). As nuclear expression of p53 is implicated in CIN in gastric cancer (Danesi et al., 2000) , we also examined p53 (Figure 4d ), and its relationship with ABI. For the intestinal-type gastric cancer, the samples negative for nuclear expression of both b-catenin and p53 showed ABI of 33% (Figure 4g ). The samples with nuclear b-catenin only (and negative for nuclear p53) showed higher ABI of 53% (Figure 4g ; Po0.05) than those negative for both. The samples with nuclear p53 only (and negative for nuclear b-catenin) also showed higher ABI of 60% (Figure 4g ; Po0.001) than those negative for both. These results are consistent with the report (Danesi et al., 2000) showing association between p53 overexpression and aneuploidy, and suggest the validity of our ABI analysis. They also indicate that b-catenin/TCF transcriptional activation contributes to CIN in the intestinal-type gastric cancer too, independent of the p53 status.
In addition, the samples with nuclear expression of both p53 and b-catenin showed higher ABI (72%) than those with either nuclear p53 only or b-catenin only. The difference in ABI between the samples with both p53 and b-catenin, and those with only p53 was statistically significant (Po0.05), whereas that between the samples with both p53 and b-catenin, and those with Chromosomal instability by Wnt signaling K Aoki et al only b-catenin was not (P ¼ 0.14). These results suggest that p53 dysfunction may have a stronger influence on CIN than Wnt signaling activation.
Discussion
It has been debated whether CIN is the cause of cancer, or is simply an accompanying phenomenon of carcinogenesis. In human colon carcinogenesis, genetic instability and CIN are found from early stages, implicating its role in colorectal tumorigenesis (Shih et al., 2001; Rajagopalan and Lengauer, 2004) . On the other hand, it has been argued that published data provide little evidence for CIN in early colorectal tumors (Sieber et al., 2003) . In later stages, chromosomal aberrations and LOH are more frequently observed, and ABI is increased (Rudolph et al., 2001) . However, the confusion may have been caused partly by the assumption that CIN is a clear qualitative phenotype derived from a unified mechanism. It is likely that CIN is a quantitative trait caused by multiple mechanisms and may play a variety of roles at various stages of tumorigenesis (Gisselsson, 2003; Rajagopalan and Lengauer, 2004) . For example, we recently showed that reduced levels of CDX2 in the colon cause CIN through acceleration of G1/S progression (Aoki et al., 2003) . Here, we have reported an additional mechanism in which b-catenin/ TCF-transcription causes CIN that appears to be mediated by dysregulation of the spindle checkpoint or subsequent apoptotic pathway, through inhibition of Cdc2 ( Figure 5 ). Although the CIN caused by Wnt signaling alone may not necessarily be so extensive as seen in full-blown human colorectal tumors, it can contribute to more marked CIN when combined with additional defects. For example, our results also suggest that p53 dysfunction and Wnt signaling may cooperate to increase CIN in the progression of the intestinal-type gastric cancer. It has been reported that APC binds to the kinetochore, and that its truncation mutations cause polyploidy (Fodde et al., 2001; Kaplan et al., 2001) . However, APC is a multifunctional protein and it plays a key role also in the canonical Wnt signaling pathway. Thus, questions arise how mutant APC protein can contribute to CIN in the respective pathways; namely, the direct interaction with the kinetochore, and transcriptional activation through b-catenin/TCF complex. Although these are relatively simple questions conceptually, they are rather difficult to answer experimentally.
First of all, Wnt signaling allows a wide dynamic range, and its activation can be regulated quantitatively. For example, upon LOH of the wild-type Apc allele, the heterozygous animal forms about 3-300 polyps/mouse (Taketo, 2006) . In contrast, the floxed Catnb allele Chromosomal instability by Wnt signaling K Aoki et al generates B3000 polyps when activated by Cre recombinase driven by the cytokeratin 19 (K19) promoter (Harada et al., 1999) . This apparent difference in the polyp number between APC and b-catenin mutations may be explained by several factors, namely, the nature of the mutations in terms of the strength of Wnt activation, and efficiency of Cre expression may affect the polyp number. Although a systematic comparison remains to be performed, circumstantial evidence is consistent with our interpretation. We recently constructed two hypomorphic Apc alleles that produce wild-type APC protein at 15-20% level of the wild-type Apc þ allele (Ishikawa et al., 2003; Li et al., 2005) . As the intestinal epithelium expressed low levels of wild-type APC even after loss of the Apc þ allele by LOH, the heterozygous mice produced only a few intestinal polyps per mouse, showing a positive correlation between Wnt signal activation and the polyp multiplicity (Li et al., 2005) . These results suggest that the relative contributions by the direct interaction of APC (and b-catenin) with the spindle structures and by transcriptional activation are affected depending on the specific mutant alleles of the putative proteins, APC and b-catenin. It is worth noting that a recent study in Drosophila shows APC mutants with separate Wnt signaling and Wnt-independent effects (McCartney et al., 2006) .
It has been reported that the homozygous Apc 1638T ES cells as well as Apc Min display CIN, whereas the product of Apc 1638T is proficient in suppressing Wnt signaling (Fodde et al., 2001) . The data suggest that the role (i.e., kinetochore binding) of APC in CIN is distinct from the Wnt signaling (Fodde et al., 2001) . However, the level of CIN is significantly lower in the Apc 1638T cells than that in Apc Min (Fodde et al., 2001) , suggesting that Wnt signal transcription plays some roles in CIN in these cells. We have shown here that the stabilizing mutation in b-catenin induces high ABI and aneuploidy at similar extents to those by the mutation in Apc (Figure 1 and Table 1 ). In addition, ABI has been reduced in the b-catenin and Apc mutant ES cells, respectively, upon inhibition of the Wnt transcriptional activity by dominant-negative TCFs. These results are consistent with the fact that activated TCF increases ABI in human colon cancer cell line DLD-1. Thus, we conclude that TCF-dependent transcription is sufficient for induction of CIN. These new data open a possibility that the major effect of APC mutations on CIN is through transcription, although it remains to be proven by further experiments.
In conclusion, the present results indicate that activation of b-catenin/TCF-mediated transcription contributes to CIN in ES cells and gastrointestinal epithelial cells, which may stimulate cancer progression.
Materials and methods

ES cells and mice
ES cells and mice were described previously (Oshima et al., 1995; Harada et al., 1999; Supplementary Information) . All animal experiments were approved by the Animal Care and Use Committee of Kyoto University.
Immunohistochemical analyses
Immunohistochemical procedures were described previously (Harada et al., 1999; Supplementary Information) .
Determination of ABI Anaphase bridges were scored as described previously (Seno et al., 2002; Aoki et al., 2003; Mizoshita et al., 2003; Supplementary Information) .
Western analyses and Cdc2 kinase assay Western blots and kinase assay were performed as described previously (Aoki et al., 2003; Supplementary Information) .
Chromosomal banding analysis
The ES cells were cultured in the presence of colcemid and the chromosomes were analysed using the GTW-banding method (Hsieh, 1997; Supplementary Information) .
Cells and plasmids DLD-1 was described previously (Aoki et al., 2003) . Plasmid construction and infection of the plasmids into the ES cells are described in Supplementary Information. Dominant-negative TCF1 and TCF4 constructs were kindly provided by Dr H Clevers, whereas TCF4DC was from Dr T Akiyama (Sekiya et al., 2004) .
Cell cycle analysis
Cells cycle analysis was performed as described previously (Aoki et al., 2003; Supplementary Information) .
Wnt transcription activity
Transfection assays with b-catenin/TCF reporter plasmids (Upstate Biotechnology, Charlottesville, VA, USA) were performed as described (Aoki et al., 2003 ; Supplementary Information). TUNEL assays ES cells were treated with nocodazole at 0.2 mg/ml for 24 h and labeled with terminal deoxynucleotidyl transferase, according to the manufacture's protocol (Wako, Japan; Supplementary Information).
